MedElevator Войти в исследования
← Поиск публикаций
The Journal of the Association of Physicians of India · 2025

National Consensus Statement on Role of Bisoprolol across Cardiovascular Continuum: Special Focus on Women.

Consensus StatementСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Chopra Hriday Kumar, Sethi Kamal Kumar, Nair Tiny, Ponde Chandrashekhar, Ray Saumitra, Rao Sarita, Sundaram Shanmunga, Khullar Dinesh, Nanda Navin C, Sawhney Jatinder Pal Singh, Bajaj Sarita, Mehta Yatin, Pancholia Ashok Kumar, Jain Pradeep, Omar Ashok Kumar, Kapoor Aditya, Sethi Rishi, Abhyankar Atul, Sharma Vinod, Dhall Anil, Sinha Ajay, Mishra Shishu Shankar, Rautray Satya Narayan, Sharma Gyarsi Lal, Mehta Ashwani, Agarwala Rajeev, Rajput Rajeev, Mahajan Ajay, Porwal Sanjay, Hotchandani Ramesh, Rastogi Vishal, Passey Rajiv, Bhargava Mohan, Paul Gnanaraj Justin, Prabhakaran Dorairaj, Singh Vivudh P, Mittal Vinod, Gupta Vitull, Bhalla Anil Kumar, Katyal Virender Kumar, Vijaylakshami Ishwarappa Balekundri, Moorthy Asha, Malhotra Poonam, Arora Vanita, Bhatia Mona, Bhat Prabhavathy, Chhabra Shibba T, Gopal Sugandhi, Deb Tripti, Gupta Preeti, Tewari Hemlata, Goel Anupam, Mishra Rekha, Singh Lovelina, Khan Zakia, Sheth Geeta, Mukhi Chandra, Kalra Inder Pal Singh, Arora Yogender Kumar, Das Uttara, Tyagi Kavita, Pathak Satya Nand, Kubba Samir, Bagga Saurabh, Mahilmaran Asha, Sattur Ameet, Tandon Rohit, Jain Dharmender, Shah Hetan, Majella Cecily, Prakash Ravi, Aggarwal Manish, Verma Ruchi, Sethi Sumit, Gujral Alka, Sood Kanika, Rawat Sonia, Kaul Varsha, Arora Surinder S, Arora Manjiti, Bhat Veena, Bali Anil Kumar, Sood Sanjay, Dawesar Shakuntala, Dawesar Bhushan K, Deka Nilakshi, Paithankar Makarand, Handa Rajiv, Parmar Nitish, Nabi Sheikh U, Garg Naveen, Sharma Sandeep, Tandon Vivek, Pabrai Manoj, Alam Samshad, Tyagi Manju, Sahay Manisha, Hotchandani Manju, Kathpalia Anupama, Kathpalia Ish, Chaudhary Sangeeta, Kukreja Kiran, Agrawal Vikas, Khan Inam D, Garg Prachi, Naryana Satya, Mangla Pawan Kumar, Mehrotra Rajiv, Garg Rajiv, Satyanarayan Upadhyayula, Malhotra Himani, Kumar Kapil, Raj Lokesh, Kalyani Shachi, Garg Vijay, Khan Ali H, Singh Harman P, Gupta Sajal, Singh T C, Rastogi Vipul, Ramteke Rahul, Bhalla Sukriti, Sanguri Ritesh, Niranjan Sumit K, Singla Rohit, Kumar Alok, Grover Anu

Аннотация

Cardiovascular diseases (CVDs) represent a significant health concern worldwide, with women facing distinct challenges in the prevention, diagnosis, and management of these conditions. In India, hypertension is a prevalent cardiovascular (CV) risk factor, affecting nearly one-third of adults, and women experience a disproportionately high burden across all age-groups. The CV continuum, which spans from risk factors to CV events and ultimately to heart failure (HF), demonstrates how the progression of CVD impacts women at each stage differently due to gender-specific mechanisms like hormonal influences, pregnancy complications and the effects of menopause. This manuscript aims to present a set of consensus statements developed by an expert panel in India, focusing on the role of bisoprolol across the CV continuum with special attention to women. The consensus was formed based on a thorough review of clinical experiences, existing clinical data and alignment with both global and regional clinical guidelines. The manuscript highlights the gender-specific CV risks faced by women, their higher mortality rates following acute cardiac events, delayed diagnoses and less aggressive treatments. It also discusses bisoprolol as an effective therapy for managing hypertension, HF and other CV conditions in women. Bisoprolol's benefits include consistent blood pressure (BP) control, improved outcomes in HF and reduced CV risks, particularly in postmenopausal women and those with comorbidities. The manuscript underscores the need for gender-tailored approaches to the CV continuum, from prevention through to management, to address these challenges and improve outcomes for women.

Предметные рубрики MeSH

FemaleHumansPregnancyAdrenergic beta-1 Receptor AntagonistsAntihypertensive AgentsBisoprololCardiovascular DiseasesHeart FailureHypertensionIndiaReview Literature as Topic